FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Three Motley Fool contributors think they've identified magnificent stocks that could double or more by 2030. Here's why they ...

The new option, which was announced by the Okanagan Health Surgical Centre and Kelowna Urology is called Rezūm Water Vapor ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy ...

ALLENTOWN - Syracuse snapped the IronPigs eight-game win streak with a 6-2 victory on Saturday night at Coca-Cola Park. Joey ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for treating cachexia and brain-related diseases. Researchers at Oregon State Un ...